<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 90 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page89.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=90">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 90 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 90</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=90"><img src="../thumb/90.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Analgesics - 3.2                                                                2020-04 / 59
       Drug interactions: Probenec.reduc.clear., absorpt. incr.with me-  Dosage: Admin.as 15 min.infus., Use oral analges. ther.as soon   Warnings and special precautions: Imp.hepat. /ren. funct., poss.
       toclopramide, salicylam. prolong elimin.half-life, poss.incr.anticoag   as poss. Do not exceed recomm.dos. Base dose on pt.weight.(non-  NSAID cross-sens., avoid in elderly with dehydrat., pre-exist.ren.dis.,
       eff.with anticoags./coumar. &/indadione derivats., incr. analges.  oedemat). 100 ml vial use restrict.to adults/ adolesc.& childr.weigh.   discont.if diarrh./ skin rash appear
       nephropathy/papill.necros./end stage ren. dis./ bladd.Ca risk with   more than 33 kg.  Drug interactions: May enhanc.coumarin anti-coag. eff.
       prolong.salicylat.ther., poss. decr.eff./incr.toxic.risk with meds.in-  Adults & adolesc.weigh.&gt;50 kg: 1 g/admin upto 4x/day. Min.interv.
       duc.liv. microsom.enzym.      betw.each admin.4 hrs. Max. dly. dos: 4 g/24 hrs.  PONSTAN, Pfizer [P/S]
                                     Adults weigh. &lt;50 kg& more than 33 kg (approx. 11 yrs): 15 mg/  Mefenamic acid.
       PARACETAMOL FRESENIUS 10 mg/ml,   kg (i.e.1,5 ml sol./kg) per admin.up to 4x/day. Min. interv.betw.each   Indications (S3): Mild to mod.pain in ac.& chron. condits., incl.
       Fresenius Kabi [P/S]          admin.4 hrs. Max.dly.dos: 60 mg/kg not exceed. 3 g/24 hrs.  pain of traumat./arthrit.or musc. origin, prim.dysmenorrh., head-
       Paracetamol                   Contraindications: Sev.hepatocellul.insuffic./ act. liv.dis.incl.al-  ache, dent.pain, menorrhag.when due to ovulat.dysfunct.bleed.,
       Indication: Short term treatm. of mild to mod.pain, & fev.when   cohol.hepatit.  anti-pyret.in febrile condits.
       oral route unsuit.            Side effects: Rare: Malaise, hypotens., incr. hepat.transaminas.lev.   Indications (S2): Post-traumat.condits.for a max. 5 days., prim.dys-
       (S3) SOL.FOR IV INFUS, 45/2.7/0531, 1188. 1 g/100 ml.  V.rare: Hypersens.incl. anaphylax., hepatit., pancreatit., thrombocy-  menorrh.for a max.3 days.
       720007-001: 10x50 ml vials, R81,59  topen., agranulocytos., leucopen., pancytopen., neutropen., anaem.,   (S2) & (S3) CAPS, [P/S] B/2.7/560.
       720008-001: 10x100 ml vials, R163,19  ren.colic/-fail., sterile pyuria. Postmarket: Thrombocytopen., tachy-  756148-112: 250 mg, 20, R28,21
       Dosage: Admin.as 15 min.infus, sngl.use. Min. interv.betw.each   card., N&V, admin.site reacts., fulmin. hepat. necros./-fail., incr.hepat.   Dosage: GI irrit.reduc.if admin.with meals. Max. durat: 7 days.
       admin: 4 hrs. Use oral analges. ther.as soon as poss.  enzym., anaphylact.shock & anaphylax., hypersens. react., angioed.,   Adults: 500 mg 3x/day.
       Pts.weigh.&gt;50 kg: 1x 100 ml vial admin.upto 4x/ day. Max.dly.dos:   erythema, flush., prurit., rash, urticar., ac.gen.exanthemat. pustulos.,   Menorrhag: 500 mg 3x/day with onset of menstr. flow x5 days or
       not exceed.4 g. &lt;50 kg and &gt;33 kg: 15 mg/kg per admin. Max.dos.  tox.epiderm.necrolys., Stev.-John. syndr.  until cessat.of flow whichever is less.
       not to exceed 60 mg/kg without exceed.max.dly.dos.of 3 g.  Warnings and special precautions: Ensure no concom.meds.  Prim.dysmenorrh: 500 mg 3x/day commenc.at onset contin.for
       Contraindications: Sev.hepatocellul.insuff., act. liv.dis.incl.al-  contain.paracet.to minim.OD risk., meds.contain.paracet.potent.fatal   max. 3 days while sympts.persist
       coh.hepatit., safety & effic.in pregn. not est., mix.with other meds.  in overdos., exceed.recomm.dos.may cause sev. liv. damage/death,   (S3) PAED.SUPPS, [P/S] 27/2.7/0561.
       Side effects: Bld.dyscras., angioed., anaphylax., hypotens., flush.,   hepatocellul.insuffic., ren. impairm./ dis., G6PD defic., chron.alcohol.,   Indications: Pain & fev.in childr.6 mnths-2 yrs. when oral ther.
       GI disturbs., pancreatit., hepatit., hepat.necros./fail., skin reacts., ren.  anorex., bulimia, cachex., malnutrit., dehydrat., hypovolaem., mannitol   not poss.
       colic/fail., ster. pyur., malaise.  content may have laxat. eff., assess.risk vs.benef.in pregn.as exper.  807435-007: 125 mg, 5, R65,17
       Warnings and special precautions: Excret.in breast milk, dos.   of IV admin. limit., breast feed., max.dly.dos.in hepat. impairm.not to   Dosage: Use for long.than 24 hrs not recomm.
       & treatm.durat.dur.pregn., no concom. meds.cont. paracet., poss.air   exceed 60 mg/kg/day (not exceed.2 g/day) in adults weigh &lt;50 kg/   Childr.6 mnths-2 yrs.weigh.not less than 10 kg: 1 supp.rect. 3x/
       embol.esp. if centr.ven.cathet.used for infus., cont.med.facil. immed. if   chron.or compensat.act.hepat.dis esp.in mild to mod. hepatocel-  day at 6-8 hr.interv.
       overdos.susp., exceed.recomm.dos.may cause sev.liv.damage, recov.  lul.insuffic./Gilberts snydr./ chron. alcohol.or malnutrit.& dehydrat.  Contraindications: Pept.ulc./intest.ulcerat., imp. ren./ hepat.
       from liv.dis., concom. phenytoin/probenecid, sev.ren.insuff., chron. al-  Interactions: Probenec.reduc.clear., salicylamide prolong elimin.  funct., other NSAIDs sensitiv., drug induc. bronchosp./allerg.rhinit./
       cohol./ malnutrit., dehydrat., hypovolaem., mild to mod.liv.impairm.,   half-life, oncom. enzyme-induc.subst.as paracet.induc.liv.injury risk   urticar., chron.GIT inflammat., epilep., concom.anticoag.ther.un-
       G6PD defic., anorex., bulaem., cachex., concom.enzyme-induc.subst.  incr., incr.risk of high anion gap metabol. acidos. (HAGMA) with   less contin. prothrombin.& fact.VII/IX & X monit.avail., safety in
       Drug interactions: Decr.effic./incr.hepatotoxic. risk with pheny-  flucloxacillin, decr. effectiven. & incr.hepatotox.risk with phenytoin,   pregn.& lactat.not est.
       toin, probenecid reduc.clear., salicylam. prolong eliminat.half-life.  poss. incr.risk of unwant.effs.with other meds., dos. of 4 g/day x4days   Side effects: GI disturbs., hepatit., pancreatit., pept. ulcerat.with/
       PARAFIZZ 500, Cipla Medpro [P/S]  with anticoags. may give INR value variat.theref. incr.INR monit.dur.  without GI haemorrh., haemolyt. anaem., bld.dyscras., anaphylax.,
       Paracetamol                   concom.use & 1 wk.aft.       gluc.intol.in diab., hyponatrem., CNS effs., vis.disturbs., convuls.,
       Indications: Mild to mod.pain & fev.  PERFALGAN PAEDIATRIC, Equity [P/S]  ear pain, palpitat., hypotens., asthma, bronchosp., dyspn., fac.
       (S0) EFFERVESC.TABS, 42/2.7/0543  Paracetamol              oed., angioed., laryng.oed., skin & subcutan.tiss.disords.incl Stev.-
       720438-001: 500 mg, 16, R20,65  Indications: Short term treatm.of mild to mod. pain & fev.when IV   Johns.syndr. / Lyell’s syndr./erythema multiforme., ren.& urin. dis-
       Dosage: Dissolv.in mouth/dispers.in small amnt. water. Do not chew.  route justif.& when other admin. routes not poss.in childr.1 yr & old.  ords., nephrot.syndr.
       Adults & childr.old.than 12 yrs: Usual. 1 tab. 3 hrly OR 1-2 tabs   (S3) SOL.FOR INFUS, A40/2.7/0053. 10 mg/ml.  Special precautions: Poss.NSAID cross-sens., discont. if diarrh/
       4-6 hrly while sympts.persist. Max.8 tabs/24 hrs.  709807-001: 500 mg, 12x50 ml vials, R168,12  skin rash exper., monit.bld. counts. & liv.funct.with prolong.ther., GI
       Contraindications: Sev.liv.funct.impairm., safety in pregn.& lactat.  Dosage: Use oral analges.ther.as soon as poss. Do not exceed   bleed./ ulcerat. & perforat.poss.without warn.signs, dehydrat., ren.
       not est., childr.und. 12 yrs.not recomm.  recomm.dos. Base dose on pt. weight (non-oedemat). Restrict use to   dis., elderly, asthma, pre-ren. condits. lead.to reduct.in ren.bld.flow/
       Side effects: Bld.dyscras., skin rash incl.urticar. somet.ser.with mu-  childr. weigh.&gt;10 kg (approx.1 yr) but &lt;33 kg (approx. 11 yrs)  vol., excl. uter./ other pathology bef.prescrib.for menorrh., ther. not
       cos.les./fev., allerg.reacts., dyspn., pancreatit., hepatit., ren.colic/fail.,   Admin.as 15 min. infus. Sngl.use only. Do not mix.with other meds.  to exceed 7 days
       sterile pyur., dermatit.                                   Drug interactions: Anticoags.effs.enhanc., poss. Li toxic.
       Special precautions: Do not exceed recomm. dos., liv.& kidn.dis.,   Childr.more than 10 kg (approx..1 yr) .up to 33 kg (approx.11 yrs):   PONSTEL, AI Pharm Ltd [P/S]
                                     15 mg/kg/admin (ie.1,5 ml sol./kg) upto 4x/day. Min.interv.betw. each
       alcohol., hepatit., phenylketonur. as cont.phenylalanine, contact med-  Mefenamic acid.
       ic. facilit.immed.if overdos.susp., fev./pain contin. at recomm.dos./  admin.4 hrs. Max.dly.dos: 60 mg/kg.  Indications (S3): Mild to mod.pain in ac.& chron. condits. in-
                                     Contraindications: Sev.hepatocellul.insuffic., act.liv.dis.incl.al-
       new sympt./swell.or redn., ther. not to be giv.long.than 3 days for fev./
       long. than 5 days for pain in childr.& 7 days in adults.  cohol.hepatit.  clude.traumat., arthrit.or muscul. origin. pain, dysmenorrh., men-
                                                                  orrh.& pyrex.
                                     Side effects: Rare: Malaise, hypotens., incr. hepat.transaminas.lev.
       Drug interactions: Hepatotox.meds.& enzym. induc. meds.incr.
       hepatotox.risk, therap.eff.poss. decr. by enzym.induc.meds., ab-  V.rare: Hypersens.incl. anaphylax., hepatit., pancreatit., thrombocy-  Indications (S2): Post traumat.condits.for max.of 5 days.
                                     topen., agranulocytos., leucopen., pancytopen., neutropen., anaem.,
                                                                  (S2) & (S3) SUSP, [P/S] 28/2.7/0704. 50 mg/5 ml.
       sorpt.acceler.by metoclopramide, cholestyram.reduc.absorpt.if giv.
       with.1 hr., incr.advers.ren.effs.risk with longt. salicylat., decr.clear./  ren.colic/-fail., sterile pyuria. Postmarket: Thrombocytopen., tachy-  810398-001: 100 ml, R19,72
                                     card., N&V, admin.site reacts., fulmin. hepat. necros./-fail., incr.hepat.
       incr.plasma half-life with probenecid pretreatm.           810398-028: 200 ml, R39,65
                                     enzym., anaphylact. shock & anaphylax., hypersens. react., angioed.,   Dosage: Admin.3xdly.with meals. Not to be cont. for long.than
       PARASPEN IV, (Aspen Pharmacare:Pharma) Pharmacare [P/S]  erythema, flush., prurit., rash, urticar., ac.gen.exanthemat.pustulos.,   7 days.
       Paracetamol                   tox. epiderm. necrolys., Stev.-John.syndr.  Childr.6 mnths & old: 25 mg/kg bm dly in div.dos or 6 mnths-1 yr:
       Indication: Short term treatm.(not exceed.24 hrs.) of mild to mod.  Warnings and special precautions: Ensure no concom.meds.   5 ml. 2-4 yrs: 10 ml. 5-8 yrs: 15 ml. 9-12 yrs: 20 ml. May be repeat.
       pain & fev.when oral route unsuit.  contain paracet.to minim.OD risk., meds.contain.paracet.potent.  as necess. up to 3xdly.
       (S3) SOL.FOR INFUS, 45/2.7/0375  fatal in overdos., exceed.recomm.dos.may cause sev. liv.damage/  (S2) & (S3) CAPS, [P/S] 28/2.7/0703.
       719180-001: 1 g/100 ml vials, R170,58  death, hepatocellul. insuffic.incl. Gilbert’s syndr., sev.ren.insuffic.,   812250-001: 250 mg, 20, R29,42
       Dosage: Do not exceed recomm.dos. Admin.as 15-min.IV infus.   G6PD defic., chron. alcohol., anorex., bulimia, cachex., chron. mal-  (S2) & (S3) FORTE TABS, [P/S] 28/2.7/0548.
       Do not mix with other prod. Use oral analges. ther.as soon as poss.  nutrit., dehydrat., hypovolaem., recov.from liv. dis., mannit.content   810371-006: 500 mg, 50, R139,83
       Pts.weigh.&gt;50 kg: 1 vial admin. up to 4x/day. Min.interv.betw.each   may have laxat.eff., assess risk vs.benef.in pregn.as exper.of IV ad-  Dosage: Adults: 500 mg 3xdly.with meals.
       admin: 4 hrs. Max.dly. dos. not to exceed: 4 g. Pts.weigh.&gt;33 kg but   min.limit., breast feed., max.dly.dos.in hepat.impairm.not to exceed   Menorrh: 500 mg 3x/day with onset of menstr. flow x 5 days or unt.
       &lt;50 kg: 15 mg/kg (i.e. 1,5 ml sol./kg) per admin.up to 4x/day. Min.  60 mg/kg/day (not exceed.2 g/day) in adults weigh &lt;50 kg/chron.or   flow cessat.whichev.is less.
       interv.betw.each admin.4 hrs. Max. dly. dos.not to exceed 60 mg/kg   compensat. act.hepat.dis esp.in mild to mod. hepatocellul. insuffic./   Prim.dysmenorrh: 500 mg 3x/day commenc.at pain onset contin.
       for pts.weigh. &lt;50  & more than 33 kg without exceed.max.dly dos.  Gilberts snydr./chron.alcohol.or malnutrit.& dehydrat.  for max.3 days while sympt. persist.
       of 3 g. Sev.ren. insuffic.(CrCl ≤30 ml/min): 6 hr min.interv.betw.  Interactions: Probenec.reduc.clear., salicylam. prolong elimin.half-  Contraindications: NSAID cross-sens., chron.inflammat.of upper/
       admin. Hepat.impairm: Do not exceed 3 g/day.  life, concom.enzyme-induc. subst.as paracet.induc.liv.injury risk incr.,   low.GIT, pept.ulc./ intest.ulcerat. hist., imp.ren./hepat.funct., epilept.,
       Contraindications: Sev.hepatocellul.insuff./act. liv. dis.incl.alco-  decr. effectiven. & incr.hepatotox.risk with phenytoin, incr. risk of   safety in pregn.& lactat.not est.
       hol.hepatit., safety & effic.not est. in childr.weigh.less than 33 kg.  high anion gap metabol.acidos. (HAGMA) with flucloxacillin., poss.  Side effects: GI disturbs.incl.bleed./ulcerat./ perforat/ cholestat.
       Side effects: Hypersens.incl.anaphylax./ angioed., bld.dyscras.,   incr.risk of unwant. effs.with other meds., dos.of 4 g/day x4 days   jaund./hepatit., CNS effs., convuls., vis. disturbs., ear pain, hypo-
       hypotens., tachycard. flush., ren. colic/fail., sterile pyur., pancreatit.,   with anticoags.may give INR value variat. theref.incr.INR monit.dur.  tens., asthma, palpits., dyspn., haemolyt.anaem., bld. dyscras. incl.
       N&V, hepatit., hepat.necros./fail., incr.hepat. transaminas. lev., skin   concom.use & 1 wk.aft.  bone marr.aplas., ac.hypersens. reacts., erythema.multiforme, urticar.,
       reacts., malaise, loc.reacts.  PONAC, Litha [P/S]          fac.oed., oed. esp.larynx., Stev.-John.syndr., Lyell’s syndr., perspirat.,
       Special precautions: Ensure no concom.meds. contain paracet.to   exfoll.dermatit., ren.fail., allerg. glomerulonephrit., papill.haematur.,
       minim.OD risk., exceed. recomm. dos.may cause sev.liv.damage, re-  Mefenamic acid.  dysur., hyponatraem., ac.interstit.nephrit., nephrot.syndr.
                                     Indications (S3): Mild to mod.pain from rheumat. condits., soft tiss.
       cov. from liv.dis., ren.dis., concom.probenecid, concom. enzyme-induc.  Special precautions: Excl.uter./other pathology bef.prescrib.for
       subst., monit.hepatotoxic.evid.& avoid large &/chron.dos.with con-  injur., dysmenorrh.& other painf.musculoskelet.condits.  menorrh., discont.in case of diarrh. / skin rash, regul.bld.counts /
       com.phenytoin, cons. benef./risk in pregn., excret.in breast milk aft.  Indications (S2): Post traumat.condits.such as pain, swell., & in-  LFT advis.dur.longt. ther., elderly & debilit., gluc.intol.in diab., de-
       oral admin., mild to mod.liv.impairm., hepatocellul./ sev.ren.insuffic.,   flammat.for max.5 days.  hydrat., ren.dis., asthmat.pts.with aspir.sens., HF, liv.dysfunct., con-
       G6PD defic., chron. alcohol./ malnutrit., excess.alcoh.intake, anorex.,   (S2) & (S3) SUSP, [P/S] Y/2.7/192. 50 mg/5 ml.  com.diurets/Li.
       bulim., cachex., hypovolaem., dehydrat.. cont.mannitol  793264-006: 100 ml, R17,11  Drug interactions: Anticoag.prolong.prothromb. time, incr.lev./
       Drug interactions: Probenec.reduc.clear., salicylam. prolong elimi-  793264-014: 200 ml, R34,23  poss.toxic.with Li.
       nat.half-life, decr.effic.& incr.hepatotox.risk with phenytoin, concom.  Dosage: Admin.with meals for max.7 days.
       enzyme induc.subst.incl.alcoh., other paracet.contain. prods.  Childr: 25 mg/kg/bm.dly.in div.dos. May be rep. 3xdly. 6 mnths.-1 yr.   RAYZON, Pfizer Laboratories (Pty) Ltd
                                     5 ml. 2-4 yrs: 10 ml. 5-8 yrs: 15 ml. 9-12 yrs: 20 ml.
       PERFALGAN, Equity [P/S]       Contraindications: Sens.to other NSAID’s with prostaglandin syn-  See Section 4.1.3
       Paracetamol                   thetase inhibit.activ., GI ulcerat. / inflamm., epilep., imp.hepat.funct.,   XEFO, Takeda [P/S]
       Indication: Short term treatm.of mild to mod.pain, & fev.when   safety in pregn.& lactat.not est.  Lornoxicam.
       oral route unsuit.            Side effects: GI disturb.& bleed., pept.ulcerat., headache, drow-  Indications Short term.treatm.of mild to mod. pain assoc.with ex-
       (S3) SOL.FOR INFUS, A38/3.2/0561. 1 g/100 ml.  sin., dizz., nervousn., vis.disturb., hypersens./ haematol.reacts.,   tra artic.inflamm., symptomat. treatm.of pain & inflammat.in osteo-
       705103-001: 12x100 ml vials, R336,23  asthma, skin rash.   arthrit.& rheumat.arthrit.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page89.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page85.html">85</a>&nbsp;&nbsp;&nbsp;<a href="page86.html">86</a>&nbsp;&nbsp;&nbsp;<a href="page87.html">87</a>&nbsp;&nbsp;&nbsp;<a href="page88.html">88</a>&nbsp;&nbsp;&nbsp;<a href="page89.html">89</a>&nbsp;&nbsp;&nbsp;<a href="page90.html">90</a>&nbsp;&nbsp;&nbsp;<a href="page91.html">91</a>&nbsp;&nbsp;&nbsp;<a href="page92.html">92</a>&nbsp;&nbsp;&nbsp;<a href="page93.html">93</a>&nbsp;&nbsp;&nbsp;<a href="page94.html">94</a>&nbsp;&nbsp;&nbsp;<a href="page95.html">95</a>
             </td>
             <td width="35%"><a href="page91.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page91.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
